Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

879
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
879
Glaucoma: Overview01:25

Glaucoma: Overview

950
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
950
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

744
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
744
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Degenerative Retinoschisis: Imaging Evidence for Two Distinct Structural Configurations.

Retina (Philadelphia, Pa.)·2026
Same author

Traction-Induced Structural Failure States in Macular Hole Formation Revealed by Volume-Rendered Swept-Source OCT.

Retina (Philadelphia, Pa.)·2026
Same author

Macular Posterior Vitreous Detachment: Mechanical Insights from Volume-Rendered Swept-Source OCT.

Retina (Philadelphia, Pa.)·2026
Same author

Retinal Blood Velocity after Intravitreal Injection for Neovascular Age-Related Macular Degeneration with Optical Coherence Tomography Using Speckle Analysis.

Retina (Philadelphia, Pa.)·2026
Same author

Dry Retina Is Not Enough: Recentering Visual Acuity in Antivascular Endothelial Growth Factor Therapy for Neovascular AMD.

Retina (Philadelphia, Pa.)·2026
Same author

Synthetic Science from Large Language Models.

Retina (Philadelphia, Pa.)·2026
Same journal

Persistent placoid maculopathy: long term outcomes and prognostic factors.

Retina (Philadelphia, Pa.)·2026
Same journal

ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

Retina (Philadelphia, Pa.)·2026
Same journal

AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES: A NOVEL SURGICAL TECHNIQUE.

Retina (Philadelphia, Pa.)·2026
Same journal

Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

Retina (Philadelphia, Pa.)·2026
Same journal

Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

Retina (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

588

UNSUSPECTED CENTRAL VISION DECREASE FROM MACULAR GANGLION CELL LOSS AFTER POSTERIOR SEGMENT SURGERY.

Richard F Spaide1

  • 1Vitreous, Retina, Macula Consultants of New York, New York, New York.

Retina (Philadelphia, Pa.)
|January 14, 2022
PubMed
Summary
This summary is machine-generated.

Sudden vision loss after vitrectomy may be caused by macular ganglion cell loss. Early detection via optical coherence tomography and ganglion cell volume analysis is crucial for diagnosis.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K
Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

2.6K

Related Experiment Videos

Last Updated: Oct 6, 2025

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

588
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.6K
Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
04:59

Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation

Published on: July 7, 2023

2.6K

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Vision Science

Background:

  • Posterior segment surgery, particularly vitrectomy, can lead to unexpected complications.
  • Vision loss following ophthalmic procedures requires thorough investigation to identify underlying causes.

Purpose of the Study:

  • To describe a novel postsurgical complication: circumscribed macula ganglion cell loss.
  • To identify this condition as a cause of unsuspected vision loss after posterior segment surgery.

Main Methods:

  • Evaluation of patients with sudden vision loss post-vitrectomy.
  • Comprehensive eye examinations including optical coherence tomography (OCT) and microperimetry.
  • Analysis of ganglion cell layer (GCL) volume and retinal nerve fiber layer (RNFL) thickness.

Main Results:

  • Eight patients experienced sudden central vision loss post-vitrectomy, with a mean visual acuity of 20/200.
  • Significantly reduced GCL volume (0.69 µm³ vs. 1.035 µm³) in affected eyes compared to fellow eyes (P < 0.001).
  • Microperimetry revealed severe depression of threshold sensitivities, indicating functional vision loss.

Conclusions:

  • Severe macular ganglion cell loss can occur following vitrectomy, leading to central vision impairment.
  • Diagnosis relies on a high index of suspicion, OCT imaging, and GCL volume assessment.
  • The frequency of this complication remains undetermined.